EMEA-000019-PIP08-12-M03

Key facts

Invented name
Votubia
Active substance
everolimus
Therapeutic area
Neurology
Decision number
P/0316/2017
PIP number
EMEA-000019-PIP08-12-M03
Pharmaceutical form(s)
  • Tablet
  • dispersible tablet
Condition(s) / indication(s)
Treatment of tuberous sclerosis complex
Route(s) of administration
Oral use
Contact for public enquiries
Novartis Europharm Limited

E-mail: paediatric.enquiries@novartis.com
Tel. +41 6132 41111

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating